Interviews with mathematics education researchers about recent studies. Hosted by Samuel Otten, University of Missouri. www.mathedpodcast.com Produced by Fibre Studios
…
continue reading
Science Education
открытые
[super 1695800]
Лучшие Science Education подкасты, которые нам удалось найти
Лучшие Science Education подкасты, которые нам удалось найти
Science education is a continuing study to unearth what science is. The field of science education includes anatomy, biology, chemistry and other scientific disciplines. Here you can find science project ideas for students of all ages and some research studies, too. These podcasts will assist not just students, but also teachers, in making science education exciting and enjoyable. Science education is a wide array subject which requires intensive studies and time. This catalog tends to provide podcasts about this subject area, to assist students and even teachers in understanding the facts and ideas in the field of science. Aside from the broader scope, there are also podcasts that tackle science and education, and these podcasts are a great source of learning not just for the younger generations but for professionals, too. Science affects us all and we apply it in our daily lives, however it may not always be obvious. Listening to podcasts, which can be followed anywhere and anytime, can help you gain knowledge of what surrounds you.
Malcolm O'Brien, a young man adopted into a life of advantage, returns to the neighborhood of his birth seeking credibility from a father he's never known. To determine his own destiny and apply privilege to a societal cause, he finds himself at odds with everyone he’s ever called family both old and new. An audio drama based on the stage play - Brother, Mine by KC Keene and Eric Dente. With an original score and songs by Matt Parker. Sound and spatial design by Will Pickens & Eric Dente Sta ...
…
continue reading
A weekly tour of the periodic table, from Chemistry World, the magazine of the Royal Society of Chemistry.
…
continue reading
Join the Chemistry World team for interviews, news and in-depth discussions of issues facing the chemistry community. Get in touch with your thoughts by tweeting @ChemistryWorld
…
continue reading
Analytical Chemistry is a peer-reviewed research journal that explores the latest concepts in analytical measurements and the best new ways to increase accuracy, selectivity, sensitivity, and reproducibility.
…
continue reading
Meet the authors of the latest popular science books, and join Chemistry World for a review and discussion of the topics the book raises. Join in on twitter by using #bookclubCW
…
continue reading
For the first 100 episodes, the Life Of The School podcast was a series of episodes where Aaron Mathieu interviewed different life science teachers to discus their path to the classroom, work in the classroom, and hopes and dreams for the future. Starting in September 2020 (episode 102), LOTS became a panel discussion podcast, exploring various issues we face in our classroom.
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Mr. Barlow discusses the VCE Biology course content. Each episode covers a discreet topic and lasts for around 5 to 20 minutes. Great to listen to a few episodes before a test and concise enough to listen to an entire semester before an exam. Episode 1 to 12 covers Unit 1. Episode 13 to 23 covers Unit 2. Episode 24 to 31 covers Unit 3. Episode 32 to 39 covers Unit 4. *** Don't forget to Download the ‘Unit 1 Biology‘, ‘Unit 2 Biology‘, ‘Unit 3 Biology‘ and ‘Unit 4 Biology‘ iPhone/iPod Touch a ...
…
continue reading
Malcolm O'Brien, a young man adopted into a life of advantage, returns to the neighborhood of his birth seeking credibility from a father he's never known. To determine his own destiny and apply privilege to a societal cause, he finds himself at odds with everyone he’s ever called family both old and new. An audio drama based on the stage play - Brother, Mine by KC Keene and Eric Dente. With an original score and songs by Matt Parker. Sound and spatial design by Will Pickens & Eric Dente Sta ...
…
continue reading
1
VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators
14:53
14:53
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
14:53In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of Blood journal. Dr. Trégouët's study conducted a genome-wide association study supplemented by transcriptome and Mendelian randomiz…
…
continue reading
1
Episode 2512: Jana Višňovská and José Cortina - coherence and fraction learning
45:27
45:27
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
45:27Jana Višňovská from the University of Queensland (Australia) and José Cortina Morfín from the National Pedagogical University in Mexico City (Mexico) discuss their article, "Curriculum and mathematical coherence: Exploring the tensions in teaching and learning number," published in ZDM Mathematics Education (Volume 57). Article URL: https://link.sp…
…
continue reading
1
Novel Treatment Targets for Hemophilia A and AML
23:42
23:42
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
23:42In this week's episode, Blood editor Dr. James Griffin interviews authors Drs. Vincent Muczynski and Mark Geyer on their latest research published in Blood. Dr. Muczynski's research asks if there could there be a better gene than the factor VIII (FVIII) gene to transfer for curative treatment of hemophilia A? Dr. Geyer then explores CAR T cells arm…
…
continue reading
1
Episode 2511: Mario Sánchez Aguilar - math ed research in Latin America
26:21
26:21
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
26:21Mario Sánchez Aguilar from the National Polytechnical Institute in Mexico City, Mexico, discusses the article, "Latin American research on mathematics education: A narrative review" and the accompanying special issue in ZDM Mathematics Education (Volume 57). Co-authors: Marcelo de Carvalho and Jhony Alexander Villa-Ochoa Article URL: https://link.s…
…
continue reading
1
Novel Differentiation Therapies for AML and Prognostic Value of PET in MM
19:52
19:52
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:52In this week's episode, Blood editor Dr. Laurie Sehn interviews three of the latest Blood authors: Drs. Vijay Sankaran, Ruud Delwel, Françoise Kraeber-Bodere. Two studies on the MECOM gene have been paired in this episode, analyzing new groundwork for potential novel myeloid differentiation therapies via repression of MECOM restoring enhancer media…
…
continue reading
1
Review Series on Platelet Heterogeneity
19:00
19:00
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:00In this Review Series episode, Blood Associate Editor, Dr. Elisabeth Battinelli discusses the Platelet Heterogeneity with authors Drs. Craig Morrell, Larry Frelinger, and Leo Nicolai. Find the full review series in volume 146 issue 24 of Blood.American Society of Hematology
…
continue reading
1
Special Episode: Maternal Health in Hematology
20:47
20:47
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
20:47In this special episode, Blood editor Dr. Laura Michaelis interviews Dr. Arielle Langer and Blood Associate editor Dr. Marc Blondon for this special Maternal Health episode. In honor of the second Maternal Health compendium, both discuss their papers featured in this special collection. Featured Articles: β-Thalassemia minor is associated with high…
…
continue reading
1
Analysis of IELSG37 Trial Results and PF4 in Stem Cell Aging
16:14
16:14
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
16:14In this week's episode, Blood editor Dr. James Griffin speaks with Drs. Emanuele Zucca and Sandra Pinho about their latest articles published in Blood. Dr. Zucca discusses his second analysis of the IELSG37 trial, where findings suggested that R-CHOP21 rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, administered every 21 days…
…
continue reading
1
Fixed-Duration Epcoritamab Combination Therapy for Relapsed or Refractory Follicular Lymphoma and Pre-Transplant Strategies for GVHD post-HSCT
22:01
22:01
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
22:01In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Lorenzo Falchi and Robert Levy on their latest papers published in Blood Journal. Dr. Falchi discusses his work on an open-label, multicenter phase 1b/2 study evaluating fixed-duration epcoritamab with rituximab and lenalidomide in 108 patients with relapsed or refractory …
…
continue reading
1
Advancing Blood Disorder Treatments Through Precision Therapeutics
15:08
15:08
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:08In this week's episode, Blood editor Dr. Laura Michaelis interviews authors Drs. Terri Parker and Peter Lenting on their latest papers published in Blood Journal. Dr. Lenting discusses his work on introducing a new therapeutic approach to von Willebrand disease with the development of a novel bispecific antibody (KB-V13A12) that links endogenous mo…
…
continue reading
1
Episode 2510: Drew Nucci - artificial intelligence and math education
35:38
35:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
35:38Drew Nucci ([email protected]) from WestEd discusses his team's ongoing work related to generative AI in schools and survey results about math and science teachers' perspectives on GenAI. WestEd's website Report on National Survey Results: https://www.amplifylearn.ai/reports/ Colleague.AI: https://www.colleague.ai/ List of episodes…
…
continue reading
1
New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials
18:36
18:36
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:36In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA could act as a first hit in lung injury, while Dr. Al-Sawaf revealed …
…
continue reading
1
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
9:36
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-cell lymphoma in a study with 245 patients. Findings show a tentative wa…
…
continue reading
1
Review Series on Follicular Lymphoma
17:38
17:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
17:38In this Review Series episode, Associate Editor Dr. Philippe Armand speaks with multiple authors about what it might look like to improve treatments follicular lymphoma, a disease that has been put on the backburner of innovation due to its generally treatable nature. Dr. Armand discusses "Treatment of relapsed and refractory follicular lymphoma: w…
…
continue reading
1
Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms
24:11
24:11
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
24:11In this week's episode of the Blood Podcast, Associate Editor Dr. James Griffin interviews Drs. Binod Dhakal and Ruben Bierings about their respective papers published in this week's issue of Blood. Dr. Dhakal presents his study on using talquetamab, a bispecific antibody, as a bridging therapy before BCMA-targeted CAR T-cell therapy in multiple my…
…
continue reading
1
Spotlight on Acute Myeloid Leukemia
21:39
21:39
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
21:39In this Spotlight series episode on Acute Myeloid Leukemia, Blood Editor, Dr. Selina Luger interviews Drs. Laura Michaelis and Alexander Perl on their paper in the series titled “The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based frontline treatment”. The conversation explores challenges in treating AML…
…
continue reading
1
Busulfan-melphalan conditioning in newly diagnosed, transplant-eligible multiple myeloma; and use of spatial transcriptomics to probe the three-dimensional properties of multiple myeloma bone marrow microenvironments ...
13:13
13:13
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
13:13In this week's episode we’ll learn more about a study comparing busulfan-melphalan with melphalan alone as the conditioning protocol for newly diagnosed, transplant-eligible multiple myeloma; then we will discuss data on how three-dimensional transcriptomics can reveal complex interactions between plasma cells and bone marrow microenvironments. Fea…
…
continue reading
1
Episode 2509: Pamela Weber Harris - developing mathematical reasoning
45:58
45:58
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
45:58Pam Harris discusses her new book series Developing Mathematical Understanding (K-12) from Corwin Press and her experiences in professional development with mathematics teachers. Pam's professional website (Math is FigureOutAble) Developing Mathematical Understanding book Developing Mathematical Understanding free workshop List of episodes…
…
continue reading
1
How I Treat Wiskott-Alrich syndrome
13:16
13:16
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
13:16In this How I Treat podcast episode, Laura Michaelis, MD interviews Sung-Yun Pai, MD about their recently published article in Blood journal "How I treat Wiskott-Alrich syndrome". They highlight recent updates in treatment, including new risk-benefit calculations due to safer treatments and longer follow-ups. Challenges include late diagnosis, lack…
…
continue reading
1
Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas
19:43
19:43
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:43In this week's episode we'll learn about targeting the tissue factor pathway inhibitor with a monoclonal antibody to rebalance HEMOSTASIS in hemophilia A and B. In the phase 3 BASIS trial, the monoclonal antibody marstacimab reduced bleeding events, and was generally well tolerated, with no unanticipated side effects. After that: matched-donor allo…
…
continue reading
1
Episode 2508: Dan Meyer - career thus far (math ed blogging, Desmos technology, Amplify)
35:16
35:16
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
35:16Dan Meyer from Amplify discusses his career thus far in mathematics education, including his work as a teacher, as a graduate student and blogger at Stanford University, and with Desmos instructional technology. Dan's old dy/dan blog Set of Three-Act Math Tasks "Math class needs a makeover" TED talk List of episodes…
…
continue reading
1
Epstein-Barr virus genomic variants in human disease states, somatic GATA1 mutations and leukemia in Down syndrome, and new definitions for high-risk multiple myeloma
18:01
18:01
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:01In this week's episode, we’ll learn more about relationships between Epstein-Barr virus genomic variants and human diseases, including hematological malignancies; the presence and timing of somatic GATA1 mutations and their relationship to a Down syndrome-specific form of leukemia; and new definitions for high-risk multiple myeloma that emphasize t…
…
continue reading
1
Review Series on Acute Lymphoblastic Leukemia (ALL)
12:38
12:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
12:38In this Review Series episode, Associate Editor Dr. Hervé Dombret speaks with Dr. Mark Litzow about the latest immunotherapy advances for Acute Lymphoblastic Leukemia (ALL). The discussion highlights innovative treatments like blinatumomab and inotuzumab, which are showing remarkable success in clinical trials, including an 85% three-year survival …
…
continue reading
1
Azacitidine holds promise in VEXAS syndrome; a step forward in precision blood matching; identifying a new vulnerability in TP53-mutated AML
18:58
18:58
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:58In this week's episode we'll learn about Azacitidine in VEXAS syndrome. Treatment can provide responses in patients with this complex autoinflammatory disorder. But relapse rates were high, so long-term therapy may be required to maintain disease control. After that: A step forward in precision blood matching. High-throughput array genotyping enabl…
…
continue reading
1
Diffuse large B-cell lymphoma’s long-term effects on immune profiles, plasminogen activation and prevention of venous thromboembolism, and PARP inhibitors in hematological malignancies carrying epigenetic ...
18:31
18:31
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:31In this week's episode we'll learn about persistent changes in immune profiles in patients who have had diffuse large B-cell lymphoma, or DLBCL, and other cancers; that plasminogen activation and plasmin activity do not appear to play a role in routine physiological prevention of venous thromboembolism, or VTE; and about a novel mechanism that make…
…
continue reading
1
“Ironing out” Tet2-mutant HSPCs; A CAR-T “license to kill” in T cell leukemia/lymphoma; insights on cHL genetics, through the lens of ctDNA
20:43
20:43
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
20:43In this week's episode, we'll learn about how TET2 is often mutated in myeloid malignancies and clonal hematopoiesis. In new work, expansion of Tet2-mutant HSPCs was dependent on Ncoa4, the cargo receptor mediating ferritinophagy. We’ll iron out the implications. After that: a double-oh-seven license to kill in T-cell leukemia/lymphoma. WU-CART-007…
…
continue reading
1
Targeting NPM1 in AML with a menin inhibitor; in primates, a CD137 ADC eliminates acute GVHD
15:10
15:10
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:10In this week's episode we'll learn about targeting NPM1 in acute myeloid leukemia. Researchers report the first clinical evidence of a menin inhibitor inducing complete remissions in AML with a NPM1 mutation. This validates NPM1 as a new therapeutic target in AML, alongside FLT3, IDH1/2, and KMT2A. Also on the podcast: targeting CD137 to prevent gr…
…
continue reading
1
How I Treat Series on Iron Overload in Hematologic Disorders
34:17
34:17
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
34:17Blood Editor, Dr. Thomas Coates interviews Dr. Emanuele Angelucci on his paper, "How I manage iron overload in the hematopoietic cell transplantation setting" which is featured in Blood's "How I Treat Series on Iron Overload in Hematologic Disorders". See the full How I Treat series in volume 145 issue 4 of Blood.…
…
continue reading
1
Early prediction of follicular lymphoma patients with poor survival; immune hotspots in aplastic anemia; role of allo-transplant for Hodgkin lymphoma in the checkpoint inhibitor era
19:49
19:49
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:49In this week's episode we'll learn about how by combining PET response with circulating tumor DNA, or ctDNA, in newly treated patients with follicular lymphoma, investigators identify those patients likely to progress within 24 months of initial treatment, also known as POD24. After that: Immune hotspots in aplastic anemia. These newly identified h…
…
continue reading
1
Exogenous CD19 stimulation in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy, sequential rapid immune-assay in heparin-induced thrombocytopenia diagnosis, and new survival prediction ...
18:42
18:42
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:42In this week's episode, we’ll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival pr…
…
continue reading
1
How I Treat series on Acute Myeloid Leukemia
42:55
42:55
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
42:55In this episode, Associate Blood editor Dr. Selina Luger leads a discussion with Drs. Courtney DiNardo, Eunice Wang, Andrew Wei and Gail Roboz about the advances in treatment options for Acute Myeloid Leukemia (AML). The conversation highlights new combinations like Venetoclax-azacitidine, challenges with differentiation syndrome, and emerging stra…
…
continue reading
1
Daratumumab maintenance in newly-diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in myeloproliferative neoplasms; and novel genetic loci associated with the risk of heavy menstrual ...
15:11
15:11
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:11In this week's episode, we’ll learn more about the effects of daratumumab maintenance on minimal residual disease in patients with newly diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in the pathophysiology of myeloproliferative neoplasms; and a genome-wide association study that identified novel genetic loci associated wi…
…
continue reading
1
Episode 2507: Amy Hackenberg - student units coordination and teacher decentering
45:03
45:03
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
45:03Amy Hackenberg from Indiana University discusses two articles from the Journal of Mathematical Behavior--"Middle school students at three stages of units coordination learn to make same speeds" (Vol. 72, 2023) and "Decentering to support responsive teaching for middle school students" (Vol. 77, 2025), both co-authored with Aydeniz-Temizer and Borow…
…
continue reading
1
Hematopoietic stem cells with enhanced transplantability, ruxolitinib for refractory macrophage activation syndrome, and magrolimab in newly diagnosed acute myeloid leukemia
18:56
18:56
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:56In this week's episode we'll learn more about enhanced transplant characteristics; targeting the JAK-STAT pathway with ruxolitinib in patients with adult-onset Still’s disease and macrophage activation syndrome; and a pair of trials demonstrating lack of benefit for the anti-CD47 monoclonal antibody magrolimab in newly diagnosed acute myeloid leuke…
…
continue reading
1
A JAK inhibitor for CRS and ICANS prevention; ChAdOx1-platelet interactions and post-vaccination arterial thrombosis; lineage switch, an emerging mechanism of leukemia relapse
18:51
18:51
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:51In this week's episode, we'll learn about a JAK inhibitor to prevent complications of CD19-directed CAR T-cell therapy. In a phase 2 study, itacitinib was well tolerated and demonstrated promising reductions in the incidence of cytokine release syndrome and neurotoxicity. After that: investigators report direct interactions between ChAdOx1 and plat…
…
continue reading
1
Ruxolitinib plus dexamethasone in newly diagnosed adult hemophagocytic lymphohistiocytosis; lysine-specific demethylase-1 inhibitors in sickle cell disease; and clinical characteristics of patients with ...
18:53
18:53
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:53In this week's episode we’ll learn more about the use of ruxolitinib plus dexamethasone to treat newly diagnosed patients with adult hemophagocytic lymphohistiocytosis; lysine-specific demethylase-1 inhibitors as a potential new class of therapies for sickle cell disease and other beta-globinopathies; and insights into clinical characteristics of p…
…
continue reading
1
Review series on mantle cell lymphoma
17:14
17:14
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
17:14In this episode, Associate Editor Dr. Philippe Armand discusses the Review Series on mantle cell lymphoma with author Dr. Christine Ryan. Both were authors of "Frontline management of mantle cell lymphoma", and discuss shifts in treatments and new research. Find the full review series in Volume 145 Issue 7 of Blood: "Review series on mantle cell ly…
…
continue reading
1
Rapid, high-sensitivity ADAMTS13 assays for TTP; combination CD38/PD-1 blockade in extranodal NK/T-cell lymphoma; a “zombie enzyme” in CREBBP-mutant lymphomas
20:08
20:08
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
20:08In this week's episode, we'll learn about rapid, high-sensitivity diagnostic assays for TTP, or thrombotic thrombocytopenic purpura, that can reduce unnecessary treatments. After that: enhancing PD-1 blockade in relapsed/refractory extranodal NK/T-cell lymphoma. In a single-arm, phase 2 study, combined CD38 and PD-1 inhibition demonstrated durable …
…
continue reading
1
Episode 2506: Digest 12 - Special Issue on Incremental Professional Development
52:41
52:41
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
52:41This episode contains summaries of the articles in the Education Sciences special issue on incremental PD for mathematics teachers. All articles are open access in this special issue and available on the journal website: https://www.mdpi.com/journal/education/special_issues/YBV49M7Q71 It has also been collected into a book, as well, from MDPI, if y…
…
continue reading
1
A novel mouse model of sickle cell SC disease; multiple myeloma induction therapy with isatuximab, carfilzomib, lenalidomide, and dexamethasone; and splicing factor mutations in myelodysplastic syndromes ...
19:08
19:08
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:08In this week's episode we’ll learn more about a novel mouse model that recapitulates many of the properties of human sickle cell SC disease; results from the induction phase of the risk-adapted MIDAS trial of isatuximab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed, transplant-eligible multiple myeloma; and a link between splicin…
…
continue reading
1
An AI model for transplant risk in myelofibrosis; preventing priapism in men with sickle cell anemia; hallmarks of T cell exhaustion absent in newly diagnosed MM
18:24
18:24
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:24In this week's episode, we'll learn about using AI to assess transplant risk in myelofibrosis. In a step toward personalized medicine, researchers report on a machine learning model that identifies 25% of patients with poor outcomes. After that: preventing priapism in men with sickle cell anemia. A recent phase 2 feasibility study shows high rates …
…
continue reading
1
Social determinants of health and access to allogeneic hematopoietic cell transplantation, megakaryocyte growth factor receptor-based pretransplant conditioning for ex vivo autologous gene therapy, and ...
19:38
19:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:38In this week's episode, we’ll learn more about social determinants of health that impact access to allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia, or AML; use of megakaryocyte growth factor receptor-based stem cell depletion as part of pretransplant conditioning in ex vivo autologous gene therapy; and identifi…
…
continue reading
1
Aggressive non-Hodgkin lymphoma: defining and managing high-risk subsets
41:28
41:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
41:28Blood editor Dr. Laurie Sehn discusses the topic of "Aggressive non-Hodgkin lymphoma: defining and managing high-risk subsets" featuring Drs. Mark Roschewski, Grzegorz Nowakowski, and Neha Mehta-Shah, who each contributed to the articles featured in the review series on high-risk aggressive lymphoma. See the full review series on high risk lymphoma…
…
continue reading
1
A key role for T-cell TET3 in chronic GVHD; a BTK inhibitor for ITP; co-inhibition of pre-TCR and IL-7R pathways in a T-ALL patient subset
20:30
20:30
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
20:30In this week's episode, we' ll learn about how TET3 has a key role in GVHD. In mice, a deficiency of Tet3 in donor T cells inhibited pathogenic immunoglobulin class switching and suppressed lung fibrosis. Accordingly, TET3 may be a new therapeutic target in chronic GVHD. After that: rilzabrutinib, a BTK inhibitor for ITP. In a randomized, placebo-c…
…
continue reading
1
Special Episode: Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma
9:47
In this special episode, Dr. Shaji Kumar from the Mayo Clinic speaks with Blood editor Dr. Laurie Sehn on a paper recently published in Blood, "Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma". The findings demonstrate eliminating the need for sequential confirmation of response in multiple myeloma. The study, invol…
…
continue reading
1
How I Treat Series on Geriatric Hematology
17:19
17:19
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
17:19In this How I Treat Series episode Dr. Thomas Ortel leads a discussion with author Dr. Patrick Foy on his paper “How I diagnose and treat thrombocytopenia in geriatric patients”. See the full How I Treat series on geriatric hematology in volume 143 issue 3 of Blood Journal.American Society of Hematology
…
continue reading
1
Single cell multi-omic analysis of leukemia stem cells, cyclophosphamide for non-immune effector cell-associated neurotoxicity, and glycosylation as a mediator of von Willebrand factor clearance
16:06
16:06
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
16:06In this week's episode, we’ll learn more about the identification and characterization of stem cell-like leukemia blasts using single cell multi-omics, cyclophosphamide as a treatment for non-immune effector cell-associated neurotoxicity in patients treated with B-cell maturation antigen, or BCMA, targeted CAR T-cell therapies, and how differences …
…
continue reading
1
Episode 2505: Julie Nurnberger-Haag - integer arithmetic in the middle grades
44:51
44:51
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
44:51Julie Nurnberger-Haag returns to the podcast to discuss the article, "Tools, tricks, and topics teachers use for integer arithmetic," published in the Electronic Journal for Research in Science and Mathematics Education (Vol. 29). Co-author: Scott Courtney Article URL: https://ejrsme.icrsme.com/article/view/23771 Julie's Google Scholar page List of…
…
continue reading
1
New insights on PU.1-mutated agammaglobulinemia; venetoclax-based induction therapy in younger AML patients; the link between ABO Blood groups and risk of future VTE
19:46
19:46
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:46In this week's episode, we'll hear about new insights into PU.1-mutated agammaglobulinemia. Researchers show that haploinsufficiency of the master transcriptional regulator PU.1 causes agammaglobulinemia and dendritic cell deficiencies. These patients experience an array of infectious and non-infectious complications, but not leukemia. After that: …
…
continue reading
1
How I Treat Transfusion Medicine (part 2)
33:57
33:57
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
33:57In part two of the How I Treat Series on Transfusion Medicine Dr. Erica Wood interviews the "How I Manage Major Hemorrhage" author group: Drs. Jeannie Callium, Keyvan Karkouti, and Ron George. Find the full published review series in Volume 145 Issue 20 of Blood Journal.American Society of Hematology
…
continue reading